Cargando…
Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease
BACKGROUND: Ticagrelor is a P2Y(12) receptor inhibitor used in acute coronary syndromes to reduce platelet activity and to decrease thrombus formation. Ticagrelor is associated with a reduction in mortality incremental to that observed with clopidogrel, potentially related to its non–antiplatelet ef...
Autores principales: | Pelletier‐Galarneau, Matthieu, Hunter, Chad R. R. N., Ascah, Kathryn J., Beanlands, Rob S. B., Dwivedi, Girish, deKemp, Robert A., Chow, Benjamin J. W., Ruddy, Terrence D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524115/ https://www.ncbi.nlm.nih.gov/pubmed/28465300 http://dx.doi.org/10.1161/JAHA.117.005894 |
Ejemplares similares
-
Static CT myocardial perfusion imaging: image quality, artifacts including distribution and diagnostic performance compared to (82)Rb PET
por: Inácio, João R., et al.
Publicado: (2022) -
Exponential dosing to standardize myocardial perfusion image quality with rubidium-82 PET
por: Tavoosi, Anahita, et al.
Publicado: (2023) -
FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: a prospective study with comparison to FDG-PET
por: Martineau, Patrick, et al.
Publicado: (2020) -
Ticagrelor versus clopidogrel in the management of acute myocardial infarction
por: Volney, Candice, et al.
Publicado: (2019) -
(82)Rb PET imaging of myocardial blood flow—have we achieved the 4 “R”s to support routine use?
por: deKemp, Robert A., et al.
Publicado: (2016)